BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rosales D, Kister I. Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder. Curr Allergy Asthma Rep 2016;16:42. [PMID: 27167974 DOI: 10.1007/s11882-016-0619-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Bogdanov EI, Kazantsev AY, Ahunova AG. Postvaccination acute disseminated encephalomyelitis with <i>area postrema</i> syndrome and quasi benign paroxysmal positional vertigo: a case report. Annals of Clinical and Experimental Neurology 2022;16:80-84. [DOI: 10.54101/acen.2022.4.10] [Reference Citation Analysis]
2 Mora Cuervo DL, Hansel G, Sato DK. Immunobiology of neuromyelitis optica spectrum disorders. Curr Opin Neurobiol 2022;76:102618. [PMID: 35973380 DOI: 10.1016/j.conb.2022.102618] [Reference Citation Analysis]
3 Szewczyk AK, Papuć E, Mitosek-szewczyk K, Woś M, Rejdak K. NMOSD—Diagnostic Dilemmas Leading towards Final Diagnosis. Brain Sciences 2022;12:885. [DOI: 10.3390/brainsci12070885] [Reference Citation Analysis]
4 Etemadifar M, Nouri H, Khorvash R, Salari M, Ghafari K, Aghababaee A. Frequency of diencephalic syndrome in NMOSD. Acta Neurol Belg 2021. [PMID: 34515964 DOI: 10.1007/s13760-021-01792-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Liu C, Shi M, Zhu M, Chu F, Jin T, Zhu J. Comparisons of clinical phenotype, radiological and laboratory features, and therapy of neuromyelitis optica spectrum disorder by regions: update and challenges. Autoimmun Rev 2021;:102921. [PMID: 34384938 DOI: 10.1016/j.autrev.2021.102921] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Exuzides A, Sheinson D, Sidiropoulos P, Magrini F, Gholizadeh S, Surinach A, Cook L, Meyer CS, Yeaman M. Burden and cost of comorbidities in patients with neuromyelitis optica spectrum disorder. J Neurol Sci 2021;427:117530. [PMID: 34111762 DOI: 10.1016/j.jns.2021.117530] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lotan I, McGowan R, Levy M. Anti-IL-6 Therapies for Neuromyelitis Optica Spectrum Disorders: A Systematic Review of Safety and Efficacy. Curr Neuropharmacol 2021;19:220-32. [PMID: 32348222 DOI: 10.2174/1570159X18666200429010825] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
8 Morelli C, Aeby A, Scaillet S, Boitsios G, Vens D, Prigogine C, Biarent D, Vicinanza A. Central Sleep Apnea Syndrome Can Complicate Neuromyelitis Optica Spectrum Disorder: A Case Report. Front Pediatr 2020;8:547474. [PMID: 33102404 DOI: 10.3389/fped.2020.547474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Czarnecka D, Oset M, Karlińska I, Stasiołek M. Cognitive impairment in NMOSD-More questions than answers. Brain Behav 2020;10:e01842. [PMID: 33022898 DOI: 10.1002/brb3.1842] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
10 Etemadifar M, Sabeti F, Ebrahimian S, Momeni F. Dorsal midbrain involvement in MRI as a core clinical manifestation for NMOSD diagnosis. Multiple Sclerosis and Related Disorders 2020;43:102150. [DOI: 10.1016/j.msard.2020.102150] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
11 Romeo AR, Segal BM. Treatment of neuromyelitis optica spectrum disorders. Curr Opin Rheumatol 2019;31:250-5. [PMID: 30920972 DOI: 10.1097/BOR.0000000000000603] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
12 Piven VD, Krasnov VS, Novikova AS, Piven FM, Kushnir YB, Totolian NA. NEUROMYELITIS OPTICA SPECTRUM DISORDERS: DIAGNOSIS AND TREATMENT, THE EXPERIENCE OF CLINICAL OBSERVATIONS. Uč zap St -Peterbg gos med univ im Akad I P Pavlova 2018;25:7-13. [DOI: 10.24884/1607-4181-2018-25-3-7-13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Sarnat HB, Flores-Sarnat L, Boltshauser E. Area Postrema: Fetal Maturation, Tumors, Vomiting Center, Growth, Role in Neuromyelitis Optica. Pediatr Neurol 2019;94:21-31. [PMID: 30797593 DOI: 10.1016/j.pediatrneurol.2018.12.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
14 Shahmohammadi S, Doosti R, Shahmohammadi A, Mohammadianinejad SE, Sahraian MA, Azimi AR, Harirchian MH, Asgari N, Naser Moghadasi A. Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review. Mult Scler Relat Disord 2019;27:350-63. [PMID: 30476871 DOI: 10.1016/j.msard.2018.11.008] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 12.4] [Reference Citation Analysis]
15 Furtado I, Pinheiro G, Campar A, Mendonça T. Association of severe and therapy-refractory systemic lupus erythematosus and neuromyelitis optica: a management challenge. BMJ Case Rep 2018;2018:bcr-2017-222139. [PMID: 29866760 DOI: 10.1136/bcr-2017-222139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Furtado I, Pinheiro G, Campar A, Mendonça T. Association of severe and therapy-refractory systemic lupus erythematosus and neuromyelitis optica: a management challenge. BMJ Case Rep 2018;2018:bcr-2017-222139. [PMID: 29866760 DOI: 10.1136/bcr-2017-222139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Miao J, Aboagye DE, Chulpayev B, Liu L, Ishkanian G, Kolanuvada B, Alaie D, Petrillo RL. Importance of Regular and Maintenance Therapy Adherence in Neuromyelitis Optica (NMO): Lessons from a Repeating Relapse Case. Am J Case Rep 2018;19:41-6. [PMID: 29321467 DOI: 10.12659/ajcr.906150] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
18 Ajmera MR, Boscoe A, Mauskopf J, Candrilli SD, Levy M. Evaluation of comorbidities and health care resource use among patients with highly active neuromyelitis optica. Journal of the Neurological Sciences 2018;384:96-103. [DOI: 10.1016/j.jns.2017.11.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
19 Han J, Yang MG, Zhu J, Jin T. Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations. Neuropsychiatr Dis Treat 2017;13:2653-60. [PMID: 29118581 DOI: 10.2147/NDT.S147360] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Snyder A, Smedley AD, Reich SG. Intractable Nausea Due to the Area Postrema Syndrome of Neuromyelitis Optica: An Uncommon Cause of a Common Symptom. The Journal of Emergency Medicine 2017;53:e73-6. [DOI: 10.1016/j.jemermed.2017.06.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
21 Han J, Yang MG, Zhu J, Jin T. Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations. Neuropsychiatr Dis Treat 2017;13:2653-60. [PMID: 29118581 DOI: 10.2147/NDT.S147360] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
22 Bakulin IS, Simaniv TO, Konovalov RN, Zakharova MN. Area postrema lesion as a cause of intractable nausea, vomiting and hiccups in neuromyelitis optica spectrum disorders. Z nevrol psikhiatr im S S Korsakova 2017;117:20. [DOI: 10.17116/jnevro201711710220-23] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
23 Ikeshima-Kataoka H. Neuroimmunological Implications of AQP4 in Astrocytes. Int J Mol Sci 2016;17:E1306. [PMID: 27517922 DOI: 10.3390/ijms17081306] [Cited by in Crossref: 70] [Cited by in F6Publishing: 76] [Article Influence: 10.0] [Reference Citation Analysis]